Anti-proliferation and anti-angiogenesis activities of Rapalogs have been well-established [1, 2], and our recent work demonstrated that activation of ER stress and the DR5/FADD-dependent apoptosis contributes significantly to their therapeutic response in colon cancer cells and xenografts [19]. Here, TNFRSF10B is linked to colonic neoplasm.